Present study | WEAVE/WOVEN | P value | |
N | 159 | 152/129 | – |
72-hour any stroke | 0.0% (0/159) | 1.3% (2/152) | 0.458 |
72-hour ischemic stroke | 0.0% (0/159) | 1.3% (2/152) | 0.458 |
72-hour hemorrhagic stroke | 0.0% (0/159) | 0.0% (0/152) | – |
72-hour death | 0.0% (0/159) | 1.3% (2/152) | 0.458 |
30-day any stroke | 2.5% (4/159) | 1.3% (2/152) | 0.721 |
30-day ischemic stroke | 2.5% (4/159) | 1.3% (2/152) | 0.721 |
30-day hemorrhagic stroke | 0.0% (0/159) | 0.0% (0/152) | – |
30-day death | 0.0% (0/159) | 1.3% (2/152) | 0.458 |
1-year any stroke | 6.3% (10/159) | 8.5% (11/129) | 0.468 |
1-year ischemic stroke | 5.7% (9/159) | 8.5% (11/129) | 0.341 |
1-year hemorrhagic stroke | 0.6% (1/159) | 0.0% (0/129) | >0.999 |
1-year death | 0.6% (1/159) | 1.6% (2/129) | 0.855 |
1-year ISR | 23.4% (15/64) | 17.6% (18/102) | 0.363 |
ISR in Mori A lesions | 15.8% (3/19) | – | – |
ISR in Mori B lesions | 15.6% (5/32) | – | – |
ISR in Mori C lesions | 53.8% (7/13) | – | – |
ISR in anterior circulation | 26.7% (4/15) | 18.8% (13/69) | 0.742 |
ISR in posterior circulation | 22.4% (11/49) | 15.2% (5/33) | 0.414 |
1-year symptomatic ISR | 3.1% (2/64) | 6.9% (7/102) | 0.495 |
1-year asymptomatic ISR | 20.3% (13/64) | 10.8% (11/102) | 0.089 |
ISR, in-stent restenosis.